212 related articles for article (PubMed ID: 32124625)
1. Effects of Treating an Overactive Urinary Bladder in Patients with Multiple Sclerosis.
Zonić-Imamović M; Imamović S; Čičkušić A; Delalić A; Hodžić R; Imamović M
Acta Med Acad; 2019 Dec; 48(3):271-277. PubMed ID: 32124625
[TBL] [Abstract][Full Text] [Related]
2. Effects of Transcutaneous and Percutaneous Tibial Nerve Stimulation in Bosnian Female Patients with an Idiopathic Overactive Urinary Bladder.
Zonić-Imamović M; Sinanović O; Imamović M; Muftić M; Janković S; Bazardžanović M
Acta Med Acad; 2021 Aug; 50(2):235-243. PubMed ID: 34847676
[TBL] [Abstract][Full Text] [Related]
3. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome.
Ramírez-García I; Kauffmann S; Blanco-Ratto L; Carralero-Martínez A; Sánchez E
Neurourol Urodyn; 2021 Jan; 40(1):295-302. PubMed ID: 33118624
[TBL] [Abstract][Full Text] [Related]
4. Effects of transcutaneous tibial nerve stimulation on females with overactive bladder syndrome in multiple sclerosis a protocol for a systematic review and meta-analysis.
Tu H; Li N; Liu W; Fan Z; Kong D
PLoS One; 2022; 17(7):e0269371. PubMed ID: 35901036
[TBL] [Abstract][Full Text] [Related]
5. Which anticholinergic drug for overactive bladder symptoms in adults.
Madhuvrata P; Cody JD; Ellis G; Herbison GP; Hay-Smith EJ
Cochrane Database Syst Rev; 2012 Jan; 1():CD005429. PubMed ID: 22258963
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the effects of transcutaneous tibial nerve stimulation or pelvic floor muscle training on sexual dysfunction in female multiple sclerosis patients reporting overactive bladder.
Polat Dunya C; Tülek Z; Kürtüncü M; Gündüz T; Panicker JN; Eraksoy M
Neurourol Urodyn; 2021 Aug; 40(6):1661-1669. PubMed ID: 34174117
[TBL] [Abstract][Full Text] [Related]
7. Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: A systematic review and meta-analysis.
Alomari MS; Abdulhamid AS; Ghaddaf AA; Alshareef KM; Haneef AK; AlQuhaibi MS; Banjar RA
Int J Urol; 2022 Oct; 29(10):1170-1180. PubMed ID: 35711082
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review.
Booth J; Connelly L; Dickson S; Duncan F; Lawrence M
Neurourol Urodyn; 2018 Feb; 37(2):528-541. PubMed ID: 28731583
[TBL] [Abstract][Full Text] [Related]
9. Transcutaneous tibial nerve electrical stimulation versus vaginal electrical stimulation in women with overactive bladder syndrome: Is there a role for short-term interventions?
Nunes JMO; Gregório EP; Moreira ECH; Hazime FA; Averbeck MA; de Almeida SHM
Neurourol Urodyn; 2023 Jun; 42(5):1101-1110. PubMed ID: 37042223
[TBL] [Abstract][Full Text] [Related]
10. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
Martin-Garcia M; Crampton J
Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
[TBL] [Abstract][Full Text] [Related]
11. Is the addition of vaginal electrical stimulation to transcutaneous tibial nerve electrical stimulation more effective for overactive bladder treatment? A randomized controlled trial.
Bacchi Ambrosano Giarreta F; Milhem Haddad J; Souza de Carvalho Fusco HC; Chada Baracat E; Casarotto RA; Alves Gonçalves Ferreira E
Actas Urol Esp (Engl Ed); 2021; 45(1):64-72. PubMed ID: 32660872
[TBL] [Abstract][Full Text] [Related]
12. Transcutaneous tibial nerve stimulation in patients with multiple sclerosis and overactive bladder: a real-life clinical and urodynamic assessment.
Hentzen C; Chesnel C; Lagnau P; Blouet E; Teng M; Amarenco G
World J Urol; 2024 Mar; 42(1):136. PubMed ID: 38478090
[TBL] [Abstract][Full Text] [Related]
13. Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial.
Manríquez V; Guzmán R; Naser M; Aguilera A; Narvaez S; Castro A; Swift S; Digesu GA
Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():6-10. PubMed ID: 26645117
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of transcutaneous tibial nerve stimulation at two different thresholds for overactive bladder symptoms in older women: a randomized controlled clinical trial.
Teixeira Alve A; Azevedo Garcia P; Henriques Jácomo R; Batista de Sousa J; Borges Gullo Ramos Pereira L; Barbaresco Gomide Mateus L; Gomes de Oliveira Karnikoskwi M
Maturitas; 2020 May; 135():40-46. PubMed ID: 32252963
[TBL] [Abstract][Full Text] [Related]
15. Transcutaneous Tibial Nerve Stimulation in the Management of Overactive Bladder: A Scoping Review.
Sayner AM; Rogers F; Tran J; Jovanovic E; Henningham L; Nahon I
Neuromodulation; 2022 Dec; 25(8):1086-1096. PubMed ID: 35688702
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the transcutaneous tibial nerve stimulation and pelvic floor muscle training with biofeedback in women with multiple sclerosis for the management of overactive bladder.
Polat Dunya C; Tulek Z; Kürtüncü M; Panicker JN; Eraksoy M
Mult Scler; 2021 Apr; 27(4):621-629. PubMed ID: 32513049
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial.
Sonmez R; Yildiz N; Alkan H
Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090
[TBL] [Abstract][Full Text] [Related]
18. Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome.
Souto SC; Reis LO; Palma T; Palma P; Denardi F
World J Urol; 2014 Feb; 32(1):179-84. PubMed ID: 23749315
[TBL] [Abstract][Full Text] [Related]
19. Treatments for overactive bladder: focus on pharmacotherapy.
Geoffrion R;
J Obstet Gynaecol Can; 2012 Nov; 34(11):1092-1101. PubMed ID: 23231848
[TBL] [Abstract][Full Text] [Related]
20. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.
Rai BP; Cody JD; Alhasso A; Stewart L
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003193. PubMed ID: 23235594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
